Barnes-Jewish Hospital at Washington University
St Louis, Missouri, 63110, United States
NCT Number: NCT03428113
ICU patients are at risk for catheter associated urinary tract infection. Frequently patients can't tell clinicians if they need to void if the catheter is removed. If clinicians know that an accurate volume measurement s of urine volume in the bladder can be obtained when the catheter is removed, catheters could be removed earlier and more frequently and thus possibly avoid an infection. For this study, measures with ultrasound (directly visualizing the bladder to measure), bladder scanner (partially blind measure with placement of scanner over the expected bladder location on the skin) and urine catheterized volume will be obtained. The investigators also want to know if the technology is user dependent. The study will include 2 levels of nurses RN and advanced practice RN (APRN) perform the bladder scanner. An APRN and MD will conduct the ultrasound. Ultrasound is technology primarily used by physicians but APRNs are using the technology technology more frequently. After these 4 measurements, the patient's nurse will perform an intermittent straight catheterization (catheter inserted, urine drained, and catheter removed) as the gold standard comparison.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
St Louis, Missouri, 63110, United States
The purpose of this correlational descriptive study is to compare measured bladder volumes with a bladder scanner (Verathon Prime), 3D ultrasound (Sono-Site II) and straight catheterization in ICU patients with low urine output receiving dialysis and in ICU patients unable to void.
Upon consent of patient or LAR, patient's age, gender and BMI with the assigned study code number will be recorded on enrollment log. Study code number, patient initials and unit will be written on bedside data collection sheet.
Sequence of 4 non-invasive (1-4) measurement will vary from day to day (see below)
Each enrolled patient will have these 4 measurements performed only on one day. Each clinician research team member will record their result on a data collection form with the study number, patient initials, day of week, clinician initials, observation of abdominal fluid, and comment section for any other observations. The clinician research team member will place the completed form for their measurement in an envelope with the study number on the outside while the next clinician is in the room obtaining the next measure.
Data collection is complete after catheter volume is recorded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Measure Urine Volume with Bladder Scanner by RN
Other names: Bladder Scanner
Measure Urine Volume with Point of Care Ultrasound by APRN
Other names: Ultrasound APRN
Measure Urine Volume with Bladder Scanner by APRN
Other names: Bladder Scanner APRN
Measure Urine Volume with Point of Care Ultrasound by MD
Other names: Ultrasound MD
Measure Urine Volume with Intermittent Straight Catheterization
Time frame: At time of enrollment, one point in time
Comparison of the two measurements of bladder volume will be analyzed
Time frame: At time of enrollment, one point in time
Comparison of the two measurements of bladder volume will be analyzed
Time frame: At time of enrollment, one point in time
Comparison of the two measurements between clinicians 1. Bladder Scan measurement by bedside RN compared to APRN bladder scan measurement) and 2. APRN Ultrasound compared to MD US will be analyzed
Washington University School of Medicine
Other
Measuring Bladder Volumes With Ultrasound and Bladder Scanning in the ICU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04232683
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Weston, Florida, United States
View Trial DetailsNCT06893562
Adherence, Documentation Skill
Mölndal, Västra Götaland County, Sweden
View Trial DetailsNCT04487600
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
View Trial DetailsNCT05064384
Digestive System Diseases, Fecal Incontinence
Little Rock, Arkansas, United States
View Trial Details